A5079484624- Mechanical Circulatory Support Devices
- Transplantation: Methods and Outcomes
- Cardiac Arrest and Resuscitation
- Cardiac Structural Anomalies and Repair
- Heart Failure Treatment and Management
- Respiratory Support and Mechanisms
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Renal Transplantation Outcomes and Treatments
- Organ Transplantation Techniques and Outcomes
- Pulmonary Hypertension Research and Treatments
- Respiratory viral infections research
- Healthcare Decision-Making and Restraints
- Geriatric Care and Nursing Homes
- Tracheal and airway disorders
- Healthcare Policy and Management
- Family and Patient Care in Intensive Care Units
- Intensive Care Unit Cognitive Disorders
- Anesthesia and Sedative Agents
- Hematological disorders and diagnostics
- Emergency and Acute Care Studies
- Simulation-Based Education in Healthcare
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumonia and Respiratory Infections
- Systemic Sclerosis and Related Diseases
- Trauma Management and Diagnosis
Vanderbilt University Medical Center
2019-2025
Pulmonary and Allergy Associates
2020-2023
Vanderbilt University
2022
Columbia University
2016-2018
New York Hospital Queens
2017-2018
NewYork–Presbyterian Hospital
2016-2018
Columbia University Irving Medical Center
2015-2017
Definitive guidelines for anticoagulation management during veno-venous extracorporeal membrane oxygenation (VV ECMO) are lacking, whereas bleeding complications continue to pose major challenges.
Bleeding and thromboembolism are common during venovenous extracorporeal membrane oxygenation. The relative frequency of these complications their impact on clinical outcomes have not been described, no randomized trials exist to guide anticoagulation strategies in Our objective was examine the frequencies bleeding thromboembolic events associations with survival among a cohort consecutive patients receiving oxygenation.Retrospective study.A single academic medical center.Adult oxygenation...
Refractory hypoxemia despite the use of extracorporeal membrane oxygenation (ECMO) for coronavirus disease 2019 (COVID-19)–related acute respiratory distress syndrome remains a challenging problem. A single ECMO circuit may not provide adequate physiologic support in setting an elevated cardiac output, demand, and impaired gas exchange. In select patients with refractory hypoxemia, addition second parallel can improve oxygenation, facilitate lung protective ventilation, awakening, physical...
Practice patterns for the use of extracorporeal membrane oxygenation (ECMO) during high-risk airway interventions vary, and data are limited. We aim to characterize our recent experience using ECMO procedural support whole-lung lavage (WLL) bronchoscopy central obstruction (CAO).We performed a retrospective cohort study adults who received WLL from 1 July 2018 30 March 2020. Our primary end point was successful completion intervention. Secondary points included ECMO-associated complications...
Extracorporeal membrane oxygenation (ECMO) is an expensive and scarce life sustaining treatment provided to certain critically ill patients. Little known about the informed consent process for ECMO or clinician viewpoints on ethical complexities related in practice.
Reports on outcomes following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in lung transplant recipients remain limited.We performed a single-center, observational study of diagnosed with SARS-CoV-2 between 5/1/2020 and 3/15/2022 that were followed for median 123 days. We analyzed changes spirometry, allograft dysfunction (ALAD) incidence, hospitalization, mechanical ventilation needs, secondary infection, survival.In our cohort 336 patients, 103 developed disease...
Coronavirus disease 2019 (COVID-19) has increased the demand for extracorporeal membrane oxygenation (ECMO) and introduced distinct challenges to patient selection ECMO. Standardized processes amidst resource limitations are lacking, data on ECMO consults underreported. We retrospectively reviewed consecutive adult acute respiratory failure received at a single academic medical center from April 1, 2020, February 28, 2021, evaluated implementation of multidisciplinary committee (ECMO...